Anke Geick

This inventor holds 28 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in RNA Interference Technology. Top assignees: Alnylam Pharmaceuticals, Inc., Axolabs Gmbh, Novartis Ag. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anke Geick. Retrieved from https://idiyas.com/inventor/anke-geick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 10)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 767(Granted Patents)

Location History:

Basel, CH (2011 - 2015)
Bayreuth, DE (2009 - 2021)

Company Filing History:

12 out of 465

Alnylam Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

Arrowhead Research Corporation

patents

Years Active: 2009-2021

Loading Chart...

Areas of Expertise:

RNAi

Alpha-ENaC

HAMP Gene

Intracellular Delivery

Lipids

Eg5 Gene

Nav1.8 Gene

Rho-A Gene

Anti-Apoptotic Genes

Biologically Active Compounds

Complex Formation

Expression Inhibition

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11208662 - RNAi inhibition of alpha-ENaC expression (2021-12-28),

2. 10544418 - RNAi inhibition of alpha-ENaC expression (2020-01-28),

3. 9914927 - RNAi inhibition of alpha-ENaC expression (2018-03-13),

4. 9636302 - Lipids and compositions for intracellular delivery of biologically active compounds (2017-05-02),

5. 9506067 - Compositions and methods for inhibiting expression of the HAMP gene (2016-11-29),

6. 9476052 - RNAi inhibition of alpha-ENaC expression (2016-10-25),

7. 9433681 - Lipids and compositions for intracellular delivery of biologically active compounds (2016-09-06),

8. 9278130 - Lipids and compositions for intracellular delivery of biologically active compounds (2016-03-08),

9. 9149531 - Lipids and compositions for intracellular delivery of biologically active compounds (2015-10-06),

10. 9090895 - Compositions and methods for inhibiting expression of the HAMP gene (2015-07-28),

11. 9074212 - RNAi inhibition of alpha-ENaC expression (2015-07-07),

12. 9057069 - Compositions and methods for inhibiting expression of Eg5 gene (2015-06-16),

13. 8791250 - Compositions and methods for inhibiting expression of the HAMP gene (2014-07-29),

14. 8691750 - Lipids and compositions for intracellular delivery of biologically active compounds (2014-04-08),

15. 8470799 - Compositions and methods for inhibiting expression of the HAMP gene (2013-06-25),

Title: Anke Geick - Innovative Inventor from Bayreuth

Introduction: Anke Geick is a pioneering inventor based in Bayreuth, Germany, known for her groundbreaking contributions to various fields through her innovative patents.

Latest Patents: Anke Geick's latest patents focus on sustainable energy solutions, advanced materials science, and cutting-edge medical technologies, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Anke Geick has established herself as a prominent figure in the world of innovation, holding numerous patents that have significantly impacted industries worldwide.

Collaborations: Throughout her career, Anke Geick has collaborated with leading research institutions, universities, and multinational companies to bring her inventions to life, demonstrating her ability to work across diverse teams and disciplines.

Conclusion: Anke Geick's passion for innovation, coupled with her dedication to pushing the boundaries of what is possible, continues to inspire the next generation of inventors and entrepreneurs in Bayreuth and beyond.

Profile summary based on public USPTO records.